Bulk Anti-Human CD19 (SJ25-C1) Antibody

In stock
Only %1 left
SKU
ICH1011
Add to Compare
$390.00

Bulk anti-human CD19 antibody (SJ25-C1)

Product Specific Citations:

Gambles, MT et al. Two-component T-cell immunotherapy enables antigen pre-targeting to reduce cytokine release without forfeiting efficacy, Nanomedicine: Nanotechnology, Biology and Medicine, Volume 67, 2025, 102825.

Product Benefits:

ichorbio's bulk anti-human CD19 antibody (SJ25-C1) is manufactured in a cGMP compliant, ISO Quality Standard 9001:2015 facility. ichorbio's low endotoxin antibodies have half the endotoxin of comparable antibodies from Bio X Cell at less than 1.0 EU/mg. If ichorbio's low endotoxin antibodies are not low enough we also offer ultra low endotoxin antibodies which have even less endotoxin (<0.5EU/mg) at an even higher purity (98% versus 95%). ichorbio: the best antibodies for in vivo research.

Target:

CD19

Clone:

SJ25-C1

Isotype:

Mouse IgG1

Other Names:

B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12,

Uniprot:

P15391

Host:

Mouse

Species Reactivity:

Human

Specificity:

Bulk anti-human CD19 antibody (SJ25-C1) recognizes an epitope on Human CD19

Purification Method:

This monoclonal antibody was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.

Antigen Distribution:

Anti-Human CD19 recognizes a (Mr 90 kDa) B-cell surface glycoprotein which is present at all stages of maturation. Anti-CD19 does not react with T-cells, granulocytes, monocytes, erythrocytes or platelets. The CD19 antigen is expressed on approximately 5-25% of human peripheral blood lymphocytes and approximately 60% of splenic lymphocytes.

Immunogen:

NALM1 + NALM16 cells

Concentration:

≥ 2.0 mg/ml

Formulation:

0.01 M phosphate buffered saline (PBS) pH 7.2, 150 mM NaCl with no carrier protein, potassium or preservatives added. BSA and Azide free.

Purity:

>95% by SDS-PAGE and HPLC

>98% by SDS-PAGE and HPLC

Endotoxin:

<0.5 EU/mg as determined by the LAL method

≤ 0.75 EU/mg as determined by the LAL method

Aggregation:

Aggregation level ≤ 5%

Aggregation level ≤ 1%

Storage:

This antibody is stable for at least 4 weeks when stored at 2-8°C. For long term storage, aliquot in working volumes without diluting and store at – 20°C or -80°C. Avoid repeated freeze thaw cycles.

Applications:

Flow Cytometry

Application Notes:

Each investigator should determine their own optimal working dilution for specific applications.

Use:

Products are for research use only.

Isotype Control:

Mouse IgG1 Isotype Control for In Vivo - Low Endotoxin [HKSP] (ICH2247)

Antibodies against the same target:

Anti-CD19 In Vivo Antibody - Low Endotoxin [1D3] (ICH1052), Anti-CD19 In Vivo Antibody - Ultra Low Endotoxin [1D3] (ICH1052UL)

Bulk anti-human CD19 antibody (SJ25-C1)

More Information
Product Specific Citations

Gambles, MT et al. Two-component T-cell immunotherapy enables antigen pre-targeting to reduce cytokine release without forfeiting efficacy, Nanomedicine: Nanotechnology, Biology and Medicine, Volume 67, 2025, 102825.

Concentration ≤ 2.0 mg/ml
Isotype Mouse IgG1
Host Mouse
Use Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Application Notes Each investigator should determine their own optimal working dilution for specific applications.
Applications Flow Cytometry
Storage anti-CD19 In Vivo Antibody - Low Endotoxin (SJ25-C1) is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at ï؟½80°C. Avoid Repeated Freeze Thaw Cyc
Endotoxin <0.5 EU/mg as determined by the LAL method
Purity >95% by SDS-PAGE and HPLC
Formulation 0.01 M phosphate buffered saline (PBS) pH 7.2 - 7.4, 150 mM NaCl with no carrier protein, potassium or preservatives added.
Purification Method This monoclonal antibody was purified using Protein A
Specificity Anti-CD19 In Vivo Antibody - Low Endotoxin (SJ25-C1) recognizes an epitope on Human CD19
Species Reactivity Human
Target CD19
Shipping Conditions Blue ice
Other names B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, Differentiation antigen CD19, T-cell surface antigen Leu-12,
clone SJ25-C1
UniProt P15391
Buffer ICH3001-100ml ICH3002-100ml ICH3003-100ml
Antigen Distribution Anti-Human CD19 recognizes a (Mr 90 kDa) B-cell surface glycoprotein which is present at all stages of maturation. Anti-CD19 does not react with T-cells, granulocytes, monocytes, erythrocytes or platelets. The CD19 antigen is expressed on approximately 5-
Immunogen NALM1 + NALM16 cells
Aggregation Aggregation level ≤ 5%
Antibodies against the same target Anti-CD19 In Vivo Antibody - Low Endotoxin [1D3] (ICH1052), Anti-CD19 In Vivo Antibody - Ultra Low Endotoxin [1D3] (ICH1052UL)
Product Benefits:

ichorbio's bulk anti-human CD19 antibody (SJ25-C1) is manufactured in a cGMP compliant, ISO Quality Standard 9001:2015 facility. ichorbio's low endotoxin antibodies have half the endotoxin of comparable antibodies from Bio X Cell at less than 1.0 EU/mg. If ichorbio's low endotoxin antibodies are not low enough we also offer ultra low endotoxin antibodies which have even less endotoxin (<0.5EU/mg) at an even higher purity (98% versus 95%). ichorbio: the best antibodies for in vivo research.

Immunogen:

NALM1 + NALM16 cells

Isotype Control:

Mouse IgG1 Isotype Control for In Vivo - Low Endotoxin [HKSP] (ICH2247)

Antibodies against the same target:

Anti-CD19 In Vivo Antibody - Low Endotoxin [1D3] (ICH1052), Anti-CD19 In Vivo Antibody - Ultra Low Endotoxin [1D3] (ICH1052UL)

Write Your Own Review
You're reviewing:Bulk Anti-Human CD19 (SJ25-C1) Antibody
Your Rating
Back to Top